A feature of the chimeric antigen receptor is the ability to recognize tumor antigens in an MHC-independent manner, which enables T-lymphocyte activation and subsequent tumor lysis by lytic granules (perforin and granzyme) [12,13]. The gene discussed is HLA-C; the disease is neoplasm.